Long-acting glatiramer acetate (GA Depot) for RRMS and PPMS announced on: March 08, 2019, 09:39:32 pm #1 This new MS drug, to be marketed for RRMS and PPMS, seems to be a "depot" version of glatiramer acetate (Copaxone), injected every 4 weeks. Just when it will become available isn't clear: Mapi Pharma to Host Key Opinion Leader Meeting on Long Acting Glatiramer Acetate (GA Depot) for Primary Progressive Multiple Sclerosis and New Treatments for MS Analyst Lunch and Live Webcast on Tuesday, March 5th at 12 Noon ET... GlobeNewswire News Room · globenewswire.com Last Edit: March 09, 2019, 09:15:49 am by agate Logged MS Speaks--online for 20 yearsSPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) 12/16/20 - 3/16/24.
Re: Long-acting glatiramer acetate (GA Depot) for RRMS and PPMS announced Reply #1 on: March 25, 2019, 07:10:40 am #2 I bet that will be expensive compared to the injections. Logged
Re: Long-acting glatiramer acetate (GA Depot) for RRMS and PPMS announced Reply #2 on: March 25, 2019, 07:26:33 am #3 The drug companies usually seem to charge whatever price the market will bear--and the sky may be the limit. Logged MS Speaks--online for 20 yearsSPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) 12/16/20 - 3/16/24.
Use of GA depot for progressive MS given US patent Reply #3 on: June 23, 2022, 09:11:19 pm #4 The injection, given every 4 weeks, is intramuscular. The main justification for bringing this new type of glatiramer acetate onto the market seems to be that it would be more convenient for people, and so patient compliance would be improved.From Multiple Sclerosis News Today (April 2, 2022)--"Use of GA Depot in Treating Progressive MS Given US Patent": GA Depot as Potential Progressive MS Treatment Given US Patent Mapi Pharma was awarded the U.S. patent for use of its long-lasting injectable glatiramer acetate form in primary, secondary progressive MS. Multiple Sclerosis News Today · multiplesclerosisnewstoday.com Logged MS Speaks--online for 20 yearsSPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) 12/16/20 - 3/16/24.
US FDA declines to approve GA Depot (yet) Reply #4 on: March 12, 2024, 09:58:17 am #5 The US FDA has declined to approve GA Depot. Apparently more information is needed, and this may be just a matter of a delay.From Neurology Live (March 22, 2024)--"FDA Issues Complete Response Letter for Long-Acting Form of Glatiramer Acetate for Relapsing Multiple Sclerosis":https://bit.ly/48QUXIA Logged MS Speaks--online for 20 yearsSPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) 12/16/20 - 3/16/24.
